Dachille Douglas A. 4
4 · BridgeBio Pharma, Inc. · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Dachille Douglas A.
Director
Transactions
- Purchase
Common Stock
2022-01-04$16.82/sh+5,000$84,100→ 5,000 total(indirect: By Trust) - Purchase
Common Stock
2022-01-05$15.91/sh+5,000$79,550→ 10,000 total(indirect: By Trust)
Footnotes (1)
- [F1]These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.